The breast cancer recurrence score test is a genomic test that extracts breast cancer tissue during surgery to check the activity of certain genes related to breast cancer, which is very helpful for the treatment of breast cancer. In addition, the breast cancer recurrence score test can also estimate the risk of early breast cancer.
This report contains market size and forecasts of Breast Cancer Recurrence Score Test in Global, including the following market information:
Global Breast Cancer Recurrence Score Test Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Breast Cancer Recurrence Score Test market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Stage I Invasive Breast Cancer Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Breast Cancer Recurrence Score Test include Roche Diagnostics, Braster, Bremed, Forward Science Technologies, Guided Therapeutics, Varian Medical Systems, LED Dental, PWB Health and Zilico Medical Diagnostics. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Breast Cancer Recurrence Score Test companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Breast Cancer Recurrence Score Test Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Breast Cancer Recurrence Score Test Market Segment Percentages, by Type, 2021 (%)
Stage I Invasive Breast Cancer
Stage II Invasive Breast Cancer
Estrogen Receptor-positive Cancer
Lymph Node-negative Breast Cancer
Global Breast Cancer Recurrence Score Test Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Breast Cancer Recurrence Score Test Market Segment Percentages, by Application, 2021 (%)
Hospitals
Speciality Cancer Centers
Advanced Diagnostic Centers
Others
Global Breast Cancer Recurrence Score Test Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Breast Cancer Recurrence Score Test Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Breast Cancer Recurrence Score Test revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Breast Cancer Recurrence Score Test revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche Diagnostics
Braster
Bremed
Forward Science Technologies
Guided Therapeutics
Varian Medical Systems
LED Dental
PWB Health
Zilico Medical Diagnostics